This year marks an important milestone — not just for Azuca, but for the partners who’ve built with us.
Together, we’ve officially reached 8 years in business and more than 700 million precisely dosed fast-acting 5mg servings infused across global medical and adult-use markets.
That growth did not happen in isolation. It happened because leading brands trusted precision. From our first national partnership with Wana Brands, one of the fastest-growing edibles brands in North America, to our first social equity collaboration with ButACake, and innovators expanding hemp and whole-plant offerings like Charlotte's Web and Flower Union, these partners have shown what consistent dosing and predictable onset can unlock at scale.
As our CEO and Co-Founder Kim Sanchez Rael shared in our recent announcement, this moment represents more than just a milestone; it signals the maturation of ingestibles and the growing importance of precision-built, regulator-ready systems as cannabis becomes part of everyday life.
And because eight years deserves more than a headline... we’re marking the moment with eight facts that showcase the scale, science, and staying power behind it!
Eight facts can’t capture all that eight years represent, but they reflect the foundation we’ve built together. This achievement belongs to our partners as much as it does to us. We’re incredibly grateful for your collaboration, trust, and ambition. You’ve helped turn precision into a category standard, and we couldn’t have done it without you. Thank you!
As we look ahead, we remain committed to delivering the consistency, predictability, and performance you can build on — today and for years to come.
